000			01837 a2200469 4500
005			20250515055529.0
264		0	_c20070816
008			200708s 0 0 eng d
022			_a0950-9232
024	7		_a10.1038/sj.onc.1210268 _2doi
040			_aNLM _beng _cNLM
100	1		_aYan, Y
245	0	0	_aIrradiation-induced G2/M checkpoint response requires ERK1/2 activation. _h[electronic resource]
260			_bOncogene _cJul 2007
300			_a4689-98 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
650	0	4	_aAtaxia Telangiectasia Mutated Proteins
650	0	4	_aCDC2 Protein Kinase _xmetabolism
650	0	4	_aCell Cycle Proteins _xantagonists & inhibitors
650	0	4	_aCell Division _xradiation effects
650	0	4	_aCell Line, Tumor
650	0	4	_aCheckpoint Kinase 1
650	0	4	_aDNA Damage
650	0	4	_aDNA Repair
650	0	4	_aDNA-Binding Proteins _xantagonists & inhibitors
650	0	4	_aG2 Phase _xradiation effects
650	0	4	_aHumans
650	0	4	_aMitogen-Activated Protein Kinase 1 _xantagonists & inhibitors
650	0	4	_aMitogen-Activated Protein Kinase 3 _xantagonists & inhibitors
650	0	4	_aNuclear Proteins _xmetabolism
650	0	4	_aPhosphorylation
650	0	4	_aProtein Kinases _xmetabolism
650	0	4	_aProtein Serine-Threonine Kinases _xantagonists & inhibitors
650	0	4	_aProtein-Tyrosine Kinases _xmetabolism
650	0	4	_aRNA, Small Interfering _xpharmacology
650	0	4	_aTumor Suppressor Proteins _xantagonists & inhibitors
650	0	4	_acdc25 Phosphatases _xmetabolism
700	1		_aBlack, C P
700	1		_aCowan, K H
773	0		_tOncogene _gvol. 26 _gno. 32 _gp. 4689-98
856	4	0	_uhttps://doi.org/10.1038/sj.onc.1210268 _zAvailable from publisher's website
999			_c16857059 _d16857059